eCite Digital Repository

Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014

Citation

Cooley, L and Dendle, C and Wolf, J and Teh, BW and Chen, SC and Boutlis, C and Thursky, KA, Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014, Internal Medicine Journal, 44, (12) pp. 1350-1363. ISSN 1444-0903 (2014) [Refereed Article]

DOI: doi:10.1111/imj.12599

Abstract

Pneumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with cancer-related immunosuppression. There are well-defined patients who are at risk of PJP due to the status of their underlying malignancy, treatment-related immunosuppression and/or concomitant use of corticosteroids. Prophylaxis is highly effective and should be given to all patients at moderate to high risk of PJP. Trimethoprim-sulfamethoxazole is the drug of choice for prophylaxis and treatment, although several alternative agents are available.

Item Details

Item Type:Refereed Article
Keywords:Pneumocystis carinii; Pneumocystis jirovecii; haematological malignancy; prophylaxis; solid-organ tumour; treatment
Research Division:Medical and Health Sciences
Research Group:Oncology and Carcinogenesis
Research Field:Oncology and Carcinogenesis not elsewhere classified
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Cancer and Related Disorders
Author:Cooley, L (Dr Louise Cooley)
ID Code:120049
Year Published:2014
Web of Science® Times Cited:22
Deposited By:Health Sciences
Deposited On:2017-08-09
Last Modified:2017-08-14
Downloads:0

Repository Staff Only: item control page